Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle
To access this article, please choose from the options below
Trial Registration #: NCT00113087.
Funded by the National Heart, Lung, and Blood Institute (Bethesda, MD), National Institutes of Health (Bethesda, MD)/Department of Health and Human Services (Washington, DC).
Supported by U01 grants from the National Heart, Lung, and Blood Institute (HL068269, HL068270, HL068279, HL068281, HL068285, HL068292, HL068290, HL068288, HL085057).
Dr. J. Michael DiMaio served as guest editor for this manuscript.
PII: S0002-8703(08)00804-1
doi:10.1016/j.ahj.2008.08.030
© 2009 Mosby, Inc. All rights reserved.
